SV

Street Verdict

Analyst Scorecard

A record of what PL Capital Analysis said publicly, with the source. Not advice.

Pending — not yet graded
“Bullish on Apollo Hospitals, suggesting a buy for upside targets of ₹9,800 and ₹10,400, with a stop loss at ₹7,000. The stock has shown signs of bottoming out near ₹7,500, with the RSI near the oversold zone indicating a positive trend reversal and significant revival.”

PL Capital Analysis’s track record (trackable calls only): 19 graded calls · 95% CI 51–88%

Apollo Hospitals Enterprise LtdBullishCalled 30 Oct 2026
Verdict:PENDING

How this call is judged

A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.

No entry price is stated, so the call starts at the first close after it was published.

Target ₹9,800, stop ₹7,000, as stated.

No time frame is stated, so it is tracked until a close reaches ₹9,800 or ₹7,000: there is no fixed window.

Open: tracking until ₹9,800 or ₹7,000 is reached on a close.

This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.

Tracking Apollo Hospitals Enterprise Ltd since this call

1-year tracking window
Read the original articleSee PL Capital Analysis’s full track record